Gray matter features of schizotypal disorder patients exhibiting the schizophrenia-related code types of the Minnesota Multiphasic Personality Inventory

Authors: Yoneyama, E.1; Matsui, M.2; Kawasaki, Y.1; Nohara, S.1; Takahashi, T.1; Hagino, H.1; Suzuki, M.1; Seto, H.3; Kurachi, M.1

Source: Acta Psychiatrica Scandinavica, Volume 108, Number 5, November 2003 , pp. 333-340(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Yoneyama E, Matsui M, Kawasaki Y, Nohara S, Takahashi T, Hagino H, Suzuki M, Seto H, Kurachi M. Gray matter features of schizotypal disorder patients exhibiting the schizophrenia-related code types of the Minnesota Multiphasic Personality Inventory.

Acta Psychiatr Scand 2003: 108: 333–340. © Blackwell Munksgaard 2003. Objective:

Previous studies have suggested that several code types of the Minnesota Multiphasic Personality Inventory (MMPI) are useful markers for identifying schizophrenia. We hypothesized that schizotypal disorder (STD) patients with such schizophrenia-related code types have the morphological brain abnormalities associated with schizophrenia. Method:

Voxel-based morphometric analysis with statistical parametric mapping (SPM) 99 software was used to investigate the differences in brain morphology between 14 STD patients with the schizophrenia-related code types of the MMPI and 28 normal individuals. Results:

The STD patients showed significantly decreased gray matter volume in the insular regions bilaterally and in the left entorhinal cortex, compared with the controls. Conclusion:

Our findings suggest that STD patients with the schizophrenia-related code types have volume reductions in these regions as an endophenotype that overlaps with schizophrenia.

Keywords: brain; magnetic resonance imaging; phenotype; schizophrenia

Document Type: Research Article

DOI: http://dx.doi.org/10.1034/j.1600-0447.2003.00202.x

Affiliations: 1: Neuropsychiatry 2: Psychology 3: Radiology, School of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan

Publication date: November 1, 2003

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page